The QualityStocks Daily Wednesday, May 17th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(IMMP) $2.6200 +64.78%

InsiderTrades(SLQT) $1.8700 +41.67%

InvestorBrandNetwork(TIO) $5.1000 +32.81%

The QualityStocks Daily Stock List

Immutep (IMMP)

TradersPro, StockMarketWatch, MarketBeat, MarketClub Analysis, BUYINS.NET, InvestorPlace, Buzz Stocks, Early Bird, HotOTC, Penny Pick Finders, PennyStockProphet, Profitable Trader Authority, QualityStocks, Real Pennies, The Street and OTCtipReporter reported earlier on Immutep (IMMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Immutep Limited (NASDAQ: IMMP) (OTC: PRRUF) (ASX: IMM) (FRA: YP1B) is a biotechnology firm that is engaged in the research and development of pharmaceutical products. The firm develops immunotherapy treatments for autoimmune diseases and cancer.

Immutep Limited provides its services across the globe and was established on May 21, 1987. The firm has its headquarters in Sydney, Australia and was known as Prima BioMed Ltd before changing its name in November 2017.

Immutep Ltd operates in the biotechnology industry under the healthcare sector and aims to develop innovative treatment options for patients who have unmet needs that need to be addressed. The firm is party to partnerships with EOC Pharma, INSIGHT, CYTLIMIC Inc., Novartis and GlaxoSmithKline.

Immutep Ltd.’s product pipeline include a recombinant protein dubbed IMP321 which is currently being assessed as a combination therapy for non-small cell lung carcinoma and neck and head squamous cell carcinoma in a phase 2 clinical trial christened TACTI-002; as well as being evaluated in a combination therapy trial, currently in phase 1 for metastatis melanoma dubbed TACT-mel. This is in addition to undergoing a phase 2b clinical trial dubbed AIPAC as a chemoimmunotherapy combination for metastatic breast cancer and another phase 1 trial dubbed INSIGHT, which is evaluating the candidate’s efficacy against advanced solid tumors. The firm’s other products include IMP731, IMP701 and IMP761, which have all been linked to lymphocyte activation gene 3.

Immutep Ltd recently announced that it will be conducting a new phase 2b clinical trial which will be evaluating the efficacy of its IMP321 candidate. Successful results of the clinical trial in treating head and neck squamous cell carcinoma may in the future help address a previously unmet need for patients who suffer from this disease. This is in addition to boosting investment in the company.

Immutep (IMMP), closed Wednesday's trading session at $2.62, up 64.7799%, on 78,984,480 volume. The average volume for the last 3 months is 3.337M and the stock's 52-week low/high is $1.47/$3.90.

GoHealth (GOCO)

Schaeffer's, MarketBeat, StreetInsider, Trades Of The Day, QualityStocks, InvestorPlace and Early Bird reported earlier on GoHealth (GOCO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GoHealth Inc. (NASDAQ: GOCO) is a digital health firm which is focused on Medicare and the health insurance marketplace.

The firm has its headquarters in Chicago, Illinois and was incorporated in 2001 by Brandon Cruz and Clint Jones. The firm sells its products through external and independent agencies as well as through online platforms and carriers. It serves consumers in the U.S.

The company provides dental, vision, accident, medical and other health insurance services and products. It operates through the IFP (Individual family plans) and Other-external; Individual family plans and Other-internal; Medicare-external; and Medicare-internal segments. The IFP external segment is involved in the sale of products and plants via the use of external agencies not employed by the company while the IPF internal segment provides vision plans, dental plans, family and individual plans, as well as other plans to people who aren’t eligible for Medicare, via agents employed by the firm who offer prospect plans from different carriers. On the other hand, the Medicare-external segment is involved in the sale of plans and products under the firm’s carrier contracts through the use of external agencies or independent agents who aren’t employed by the firm while the Medicare-internal segment comprises of the sale of plans and products by agents employed by the firm. The company’s products include Medicare special needs plans, prescription drug plans and supplements.

The enterprise recently entered into an exclusive agreement with GoodRx Inc., which will enable the firm to provide its engagement and enrollment solutions to GoodRx users on its platform, directly. The move will extend the firm’s consumer reach and bring in more revenue, in addition to increasing investments into the firm, which will have a positive effect on its growth.

GoHealth (GOCO), closed Wednesday's trading session at $16.25, up 20.0148%, on 139,704 volume. The average volume for the last 3 months is 451,640 and the stock's 52-week low/high is $4.935/$19.8464.

Viva Gold (VAUCF)

We reported earlier on Viva Gold (VAUCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viva Gold Corp (OTCQB: VAUCF) (CVE: VAU) (FRA: 7PB) is an exploration and development company focused on acquiring, exploring for and developing precious metal properties.

The firm has its headquarters in Langley, Canada and was incorporated in 2009, on September 24th. Prior to its name change, the firm was known as Aintree Resources Inc. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers.

The enterprise primarily explores for gold. It holds 100% interest in the Tonopah gold project, which covers an area of roughly 10,250 acres and is located in the Walker Lane Trend in Western Nevada, 30 miles south of Round Mountain and 30km northeast of Tonopah. This project comprises of 513 unpatented mineral claims which are located in the Ralston Valley, on the northeast side of the San Antonio Mountains in the Walker Lane structural trend of west-central Nevada. The projects are estimated pit-constrained resources at over 394,000 measured and indicated resource ounces, with an additional 206,000 ounces of inferred resource. 176 of the unpatented claims are subject to a 2% Net Smelter Return Royalty (NSR) while the remaining 337 claims are not subject to any royalty.

The company remains focused on building market awareness as it advances its technical, environmental and social baseline study work at Tonopah to support future project development. This, in turn, highlights its commitment to de-risk and add value to the project while also generating value for its shareholders.

Viva Gold (VAUCF), closed Wednesday's trading session at $0.134, off by 4.2857%, on 24,752 volume. The average volume for the last 3 months is 36,781 and the stock's 52-week low/high is $0.03774/$0.154.

Alliance Entertainment (AENT)

We reported earlier on Alliance Entertainment (AENT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Alliance Entertainment Holding Corporation (OTC: AENT) is a media distribution company operating as a wholesaler, distributor and e-commerce provider for the global entertainment industry.

The firm has its headquarters in Plantation, Florida and was incorporated in 1990 by Joseph J. Bianco. It operates as part of the entertainment industry, under the communication services sector. The firm serves consumers in the United States.

The company aims to be a one-stop-shop for solutions that address client and consumer needs from A to Z.

The enterprise offers 485,000 in stock keeping unit (SKUs), including over 57,300 exclusive compact discs, vinyl LP records, Blu-rays, digital optical disc (DVDs) and video games. It also provides integrated services, and end-to-end e-commerce solutions. It offers a range of consumer electronics and accessories from various brands, such as Audio-Technica, Vinyl Styl, Stanton, TEAC, Jensen, Numark, Ion, Thorens, and Music Hall. This is in addition to providing an assortment of headphones, mixers, amplifiers, cellphone accessories, audio and video cables, and carrying cases. The enterprise’s brands include COKeM International, AMPED Distribution, Vinyl Styl, NCircle Entertainment and Mill Creek Entertainment. It distributes its physical media, entertainment products, hardware, and accessories through using a multi-channel strategy.

The firm, which recently announced a new record for physical vinyl sales during its latest Record store day event, remains committed to helping omni-channel retailers expand their product selection and fulfillment goals, extending its global reach and better meeting consumer needs through its service offerings.

Alliance Entertainment (AENT), closed Wednesday's trading session at $3, even for the day, on 2 volume. The average volume for the last 3 months is 15.184M and the stock's 52-week low/high is $1.71/$12.24.

Blue Water Biotech (BWV)

QualityStocks, MarketClub Analysis, INO Market Report, MarketBeat, The Stock Dork, StockOnion, ProfitableTrading, Profitable Trader Authority, PennyStockScholar, PennyStockProphet, Penny Pick Finders, OTCtipReporter and Buzz Stocks reported earlier on Blue Water Biotech (BWV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Blue Water Biotech Inc. (NASDAQ: BWV) (FRA: J4T) is a biotechnology firm that is focused on researching and developing vaccines to prevent infectious illnesses.

The firm has its headquarters in Cincinnati, Ohio and was incorporated in 2018, on October 26th by Joseph Hernandez. Prior to its name change, the firm was known as Blue Water Vaccines Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is focused on developing transformational treatments to address significant health challenges globally. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company also licenses the NoV S&P vaccine platform from Cincinnati Children’s Hospital Medical Center to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, among others.

The enterprise's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. Its universal flu vaccine offers protection from all virulent strains. It also develops other products that are under preclinical development, including BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program; and BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program.

The firm, which recently announced its latest financial results, is focused on advancing its rebrand into a commercial-stage biotechnology firm and occupying a larger share of the market.

Blue Water Biotech (BWV), closed Wednesday's trading session at $1.03, off by 0.961538%, on 117,841 volume. The average volume for the last 3 months is 1,100 and the stock's 52-week low/high is $0.91/$8.00.

Positron (POSC)

PennyTrader Publisher, QualityStocks, HotOTC, HyperGrowthStock, CoolPennyStocks, StockEgg, Stock Traders Chat, Penny Invest, PennyStockVille, Pumps and Dumps, MadPennyStocks, Stock Preacher, PennyInvest, Stock Source, Stock Stars, FeedBlitz, Stockpalooza, Market Wrap Daily, StockRich, BullRally, Stock Rich,, Live2TradeWizely, MicrocapVoice,, NYStockReport,, OTCJournal,, Penny Stocks Finder, CRWEFinance, ChartPoppers, BestOtc,, PennyTrader, WallstreetsHotteststocks, USA Market News, Trading News Bulletin, Top Secret Stocks, StockProfessors, StockHideout, Stock Spike,, Penny Picks, Sling-Shot-Stocks,, PennyStockShark, WiseAlerts, Penny Stock Finder, Beacon Equity Research, Otcstockexchange, OTCReporter, OTCPicks, and SmallCapNetwork reported earlier on Positron (POSC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Positron Corporation (OTC: POSC) is a nuclear medicine healthcare firm that specializes in the business of cardiac positron emission tomography (PET) imaging.

The firm has its headquarters in Niagara Falls, New York and was incorporated in 1983, on December 20th by Roman Olinyk. It operates as part of the medical devices industry, under the healthcare sector. The firm mainly serves the healthcare industry in the United States.

The company operates through the Medical Equipment and Radiopharmaceuticals segments. It offers economical, end-to-end solutions for Positron Emission Tomography (PET) myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals, and radioisotopes.

The enterprise’s PET technology, clinical services and practice solutions enable healthcare providers to more accurately diagnose coronary artery disease and improve patient outcomes while practicing medicine. Its offerings include nuclear cardiologists’ Attrius PET scanner, service, clinical expertise and financing solutions. Its PET imaging allows identification of coronary flow reserve, a measurement that detects the blood flow differences between rest and stress through the coronary arteries. It offers a state-of-the-art PET/CT imaging device that enables nuclear cardiologists to utilize the full power of nuclear imaging. The enterprise’s other products include Dash Panels, Switch/Audio Panels, Misc. Signage, Wire Harnesses, Plastic Sheet Lamination and 12 Volt Electronics.

The firm recently entered into a new agreement with Ochsner Clinic Foundation to study its new PET-CT imaging device. This will not only help gather safety and effectiveness data but also help the firm to better meet the demands of the expanding nuclear imaging device market.

Positron (POSC), closed Wednesday's trading session at $1.24, off by 11.6746%, on 1,072 volume. The average volume for the last 3 months is 108,741 and the stock's 52-week low/high is $0.42/$2.25.

Transat AT (TRZBF)

MarketBeat reported earlier on Transat AT (TRZBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Transat A.T., Inc. (OTC: TRZBF) (TSE: TRZ) (FRA: 1TZ) is an integrated global tourism firm that is focused on providing organization, marketing and distribution of holiday travel services.

The firm has its headquarters in Montreal, Canada and was incorporated in 1987, on February 13th by Philippe Sureau, Lina De Cesare and Jean-Marc Eustache. It operates as part of the travel services industry, under the consumer cyclical sector. The firm serves consumers around the globe.

The company strives to serve its customers with friendliness and enthusiasm at every stage of their stay or trip, while also placing an emphasis on safety.

The enterprise’s business comprises of various destinations and airlines, offering international and Canadian destinations, and is vertically integrated with its other services of holiday packages, distribution through a dynamic travel agency network and value-added services at travel destinations. It flies to international and Canadian destinations serving its customers at every stage of their trip or stay. Its air transportation program includes flight operations, operational control, aircraft maintenance, cabin operations, ground handling, cargo operations, and security. Its destination service offers a broad range of products for customers for outgoing tour operators such as hospitality and representation, passenger transfers, excursions, tours, sports and other activities, and specialty services includes destination weddings, teambuilding, etc.

The company recently partnered with Iberostar Hotels & Resorts and the University of Guelph's School of Hospitality, Food and Tourism Management for an international field study program, a move that not only highlights the stride it’s made to advance sustainable travel but will also open the company up to new growth and investment opportunities.

Transat AT (TRZBF), closed Wednesday's trading session at $2.76, up 4.1509%, on 100 volume. The average volume for the last 3 months is 5,700 and the stock's 52-week low/high is $2.0018/$3.40.

Vision Sensing Acquisition Corp. (VSAC)

We reported earlier on Vision Sensing Acquisition Corp. (VSAC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vision Sensing Acquisition Corp. (NASDAQ: VSAC), a special purpose acquisition company, is working with Newsight Imaging Ltd. on a planned business combination. Newsight CEO Eli Assoolin talks about the merger in the latest release from the Bell2Bell podcast series. Newsight Imaging is a leading semiconductor innovator that is focused on developing proprietary 3D machine vision sensors, spectral vision chips and systems. During the episode, Assoolin shares his background and journey to Newsight while also providing background on the VSAC business collaboration and insight into the potential for the semiconductor space. Bell2Bell is a podcast series released by IBN, a multifaceted communications organization engaged in connecting public companies to the investment community. “About a year-and-a-half ago, we were looking at how to bring Newsight into its next phase — how to rebrand the company and land in the U.S. while making us a better choice for our customers,” said Newsight CEO Eli Assoolin during the interview. “We came to the conclusion that we needed to go public somewhere. Eventually, Vision Sensing found us and submitted an offer to merge. Since then, we’ve been working together on a merger that’s expected to be completed soon.”

To view the full episode, visit

To view the full press release, visit

About Vision Sensing Acquisition Corp.

Vision Sensing Acquisition Corp. is a Special Purpose Acquisition Company (“SPAC”) that has been established to focus on the acquisition of vision-sensing technologies, including hardware solutions (chips/modules/systems), related application software, artificial intelligence and other peripheral technologies that assist to integrate and/or supplement VST applications. For more information about the company, please visit

Vision Sensing Acquisition Corp. (VSAC), closed Wednesday's trading session at $10.61, up 0.09434%, on 34,661 volume. The average volume for the last 3 months is 460,815 and the stock's 52-week low/high is $10.00/$10.63.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, StreetInsider, Schaeffer's, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Interest in psychedelics has increased greatly in the last decade or so, as new studies into the treatment of various mental health conditions using these drugs are conducted. As more positive benefits are discovered, we have seen changes to laws that previously prohibited access to the use of psychedelics as well as the emergence of psychedelic NGOs and psychedelic startups.

In an effort to inform harm reduction and education programs that address illicit and legal use of psychedelics, researchers looked into information-seeking behaviors of individuals who used psychedelics. The study was led by Dr. Daniel Kruger, a researcher at the Institute for Social Research. Its findings were published in the “Journal of Psychoactive Drugs.

The researchers were focused on examining the information sources used by individuals who used psychedelics in their natural environments and the degree to which they trusted this information. While official advice on the use of psychedelics by trained health professionals is scanty, we know that people who use psychedelics often engage in substantial gathering and sharing of information.

The researchers believe that the Schedule I classification of psychedelics has driven individuals to underground environments to seek information on harm reduction and guidance on how the drugs are to be used. For their research, the investigators carried out an anonymous online survey. They determined that users of psychedelics consulted different sources of information, all of which were not typical medical care and mainstream health systems.

Of the total study population, more than 80% had used at least two different psychedelics, with most of the participants having used the drugs at least once every six months in the last five years.

The researchers found that individual experiences and experimentation was the most common source of information on psychedelics for participants. Some also went to friends, websites, internet books and discussion forums as well as articles in peer-reviewed scientific journals.

In addition, the researchers found that fewer than 5% of the participants went to their primary healthcare providers, with an even smaller number admitting that they didn’t seek any information. Furthermore, the researchers observed that older individuals were more likely to seek information from psychedelic therapists, in comparison to younger participants.

In the report, Kruger noted that having trusted information sources was important as it heightened the likelihood of responsible and safe use. The researchers hope that their findings will help to better inform public health officials, policy makers and clinicians who work with psychedelic users.

Such studies showing how users of psychedelics are accessing information should give startups such as Compass Pathways PLC (NASDAQ: CMPS) plenty to think about regarding how best they can help members of the public gain access to reliable and timely information about this rapidly evolving industry.

Compass Pathways PLC (CMPS), closed Wednesday's trading session at $8.5, up 1.3111%, on 129,738 volume. The average volume for the last 3 months is 964,912 and the stock's 52-week low/high is $6.97/$21.50.

Freeport-McMoRan Inc. (FCX)

MarketClub Analysis, The Street, InvestorPlace, Schaeffer's, Kiplinger Today, SmarTrend Newsletters, StocksEarning, MarketBeat, Barchart, StreetAuthority Daily, Trades Of The Day, StreetInsider, Investopedia, Money Morning, TopStockAnalysts, Daily Trade Alert, Zacks, Louis Navellier, VectorVest, Trading Markets,, The Growth Stock Wire, ProfitableTrading, QualityStocks, Daily Wealth, The Wealth Report, Top Pros' Top Picks, TheStockAdvisors, The Online Investor, All about trends, Trading Tips, Wall Street Elite, StreetAlerts, Leeb's Market Forecast, TradingMarkets, Streetwise Reports, Market FN, Dividend Opportunities, TheStockAdvisor, Market Report, Early Bird, StockEarnings, Investor Guide, InvestmentHouse, StockTwits, Investors Alley, Trading Concepts, Wealth Insider Alert, Investment House, Money and Markets, DividendStocks, Options Trader Elite, INO Market Report, Cabot Wealth, InvestorGuide, The Best Newsletters, Market Intelligence Center Alert, Wyatt Investment Research, Investing Signal, Wealth Daily, Trade of the Week, Bourbon and Bayonets, Darwin Investing Network, The Motley Fool, Energy and Capital, Buttonwood Research, AnotherWinningTrade, Investor Update, MarketWatch, Market Authority, Wealthpire Inc., Profit Confidential, Street Insider, TradingAuthority Daily, Wall Street Daily, Stock Research Newsletter, Super Stock Investor, AllPennyStocks, Dynamic Wealth Report, CNBC Breaking News and Daily Markets reported earlier on Freeport-McMoRan Inc. (FCX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gold has always been used as a safe haven asset, especially during times of uncertainty or rising inflation. This is primarily because the precious metal retains its value and helps investors limit exposure to loss during market turbulence.

During the coronavirus pandemic, which affected economies globally, gold became a favorite of investors. During the last three years, the precious metal has surged 18%, and it has risen by 41% in total over the last decade. Additionally, one poll determined that one-quarter of Americans consider gold a good asset to invest in long-term.

The price of gold is set to hit a new record as more investors turn to the precious metal in this volatile environment. So far this year, the price of gold has risen by 10%. Gold mining stocks have recorded surges, with shares of Kinross seeing a 27% rise. Gold Fields, Royal Gold, Franco-Nevada and Barrick Gold shares have also trended up, reporting 50%, 19%, 14% and 10% increases respectively.

Analysts expect that the looming recession will afford the precious metal even more time to run. Mark Haefele, global chief investment officer at UBS, stated in a note that gold could soon surpass its all-time high. Haefele set a $2,200 target for the precious metal for March 2024, which equates to an 8% increase. He believes that stress in the banking sector, a weakening U.S. dollar, easing expectations on interest rates and the growing likelihood of a recession all strengthen the precious metal’s prospects.

Cleve Rueckert, another analyst at UBS added that gold was driven by macro variables such as the influence of the U.S. dollar and real rates in the U.S., rather than demand and supply. He explained that the increase in the price of this metal was unique and had very little to do with its uses.

Edward Moya, an analyst at Oanda, stated that the excess of risk in America and abroad would add fuel to the demand for the precious metal, noting that this was a win-win scenario for gold.

To gain gold exposure, investors should consider purchasing futures contracts for gold or physical gold. This is in addition purchasing shares of public companies that mine the metal or buying exchange traded funds (ETFs) holding the precious metal.

Not everyone backs the idea of investing in this particular metal though. For instance, Warren Buffett, a billionaire and legendary investor in his own right, has for a while now maintained that investing in gold doesn’t produce any value.

For investors interested in acquiring gold stocks, it is advisable to do ample due diligence on several companies, such as Freeport-McMoRan Inc. (NYSE: FCX), before making a final decision on where to put your money.

Freeport-McMoRan Inc. (FCX), closed Wednesday's trading session at $35.82, up 1.617%, on 14,459,650 volume. The average volume for the last 3 months is 24,193 and the stock's 52-week low/high is $24.80/$46.73.

Lordstown Motors Corp. (RIDE)

Green Car Stocks, Schaeffer's, QualityStocks, InvestorPlace, StocksEarning, The Street, StockEarnings, MarketBeat, MarketClub Analysis, Trades Of The Day, Early Bird, Daily Trade Alert, The Online Investor, Investopedia, CNBC Breaking News, GreenCarStocks, Kiplinger Today, StreetInsider, BUYINS.NET, The Stock Dork and Cabot Wealth reported earlier on Lordstown Motors Corp. (RIDE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The 2023 Rev Up report from the Sierra Club’s poll on shopping experiences this year revealed that 66% of auto dealers in the United States have no electric vehicles to sell, and 45% claimed they would not sell any under any circumstances. According to the report, 44% of the 66% of auto dealers without any electric vehicles would like to sell them whenever possible. The ones that seek to sell electric vehicles claim that the stock constraints are the result of supply network problems and inventory problems, as well as electric vehicle manufacturers’ allotment to dealerships.

In comparison to all other areas of the country, the Western area had the lowest percentage of dealerships (27%) with an electric vehicle for sale. Yet, the same Western area sold considerably more electric vehicles as compared to other areas across the country and was responsible for 45% of all sales of electric vehicles last year, showing that the limited availability is due to high demand from customers and high turnover in sales.

The report noted that 27 states prohibit automakers such as Rivian and Tesla from selling direct to motorists, and this has an effect on sales of electric vehicles: 65% of electric vehicles were sold in states that permit direct selling.

According to the Sierra Club, if supply and inventory concerns were not an issue, additional dealers within the 13 U.S. states having zero-emission vehicle (ZEV) initiatives said they would provide electric vehicles. The researchers discovered that 61% of all EV sales in the country occurred in ZEV states last year, while the 35 states without ZEV policies sold 39% of all electric vehicles. That seems to confirm that the ZEV policy is effective.

As for vehicle brands, the participants in this study reached out to auto companies represented by 18 vehicle ownership organizations. The most EVs available were from Mercedes-Benz. From the Mercedes-Benz outlets examined, 90% had an electric vehicle on sale.

Honda and Toyota faced the worst availability of electric vehicles. Toyota held second-to-last place, with only 15% of its dealerships having an electric vehicle on sale, followed by Honda, which had 11% of its dealers in last place.

The authors of the Sierra Club advise automakers to work with suppliers to provide them with electric vehicle chargers on the ground. The report also suggested offering training to salespersons regarding charging of electric vehicles, consumer subsidies and successful sales techniques as well as publicly exhibiting electric vehicles.

The number of dealerships that are interested but are unable to access EV inventories should give startups such as Lordstown Motors Corp. (NASDAQ: RIDE) an opportunity to bridge the gap and get a stronger foothold in the market.

Lordstown Motors Corp. (RIDE), closed Wednesday's trading session at $0.2955, off by 5.8017%, on 6,317,631 volume. The average volume for the last 3 months is 1.947M and the stock's 52-week low/high is $0.251/$3.73.

Canaan Inc. (CAN)

QualityStocks, MarketClub Analysis, Schaeffer's, InvestorPlace, TradersPro, StreetInsider, Stockhouse, MarketBeat, AllPennyStocks, INO Market Report, StockEarnings, BUYINS.NET, CryptoCurrencyWire, InvestorsUnderground, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In recent months, the cryptocurrency sector has experienced several setbacks, including bankruptcies, the arrest of FTX founder Sam Bankman-Fried and regulatory action against leading exchange Binance. But despite everything happening, the cost of Bitcoin, the largest crypto, has increased.

Bitcoin’s value has increased by 65% this year, outpacing the S&P 500’s 7% increase by a wide margin. Even the NASDAQ, a heavily weighted index for technology, has only produced a fraction of Bitcoin’s gains.

According to analysts, Bitcoin has actually profited from the cryptocurrency crisis since the upheaval has driven investors away from unpopular coins and toward the market leader. Additionally, the price has been boosted by broader economic dynamics, such as financial system problems and slower interest rate hikes.

However, the upcoming months are unpredictable, according to the experts, since a potential recession could put a young (under 15 years old) digital asset’s performance to the test.

Bitcoin’s explosive performance in 2023 comes as a surprise after falling precipitously in value the previous year. Bitcoin’s price decreased by 65% overall last year, which was more than twice the S&P 500’s 20% decline. Bitcoin’s price drops, which affected a large portion of the cryptocurrency market, occurred at the same time as a rash of aggressive interest rate increases that put negative pressure on a variety of assets, including the main stock indices.

A multitude of failures were prompted by the crypto crisis. For starters, Terra and its sibling counterpart, Luna, both collapsed in May of last year. Additionally, numerous cryptocurrency lenders, including Genesis, Celsius and Block Fi, declared bankruptcy in 2022. In a stunning turn of events, the cryptocurrency exchange FTX also declared bankruptcy in November following a quick collapse that was followed by the arrest of its founder. Bankman-Fried has entered a not-guilty plea to all 13 of the charges against him, including conspiracy and fraud.

The surge in Bitcoin’s price has corresponded with positive trends in the broader economy as the Federal Reserve has paused its interest rate hikes and dissatisfaction with the traditional banking system has prompted most investors to seek refuge in digital assets.

Three of the top 30 banks in the country have collapsed since March. The regional lender PacWest Bancorp’s stock crashed on Thursday after the bank reported losing 9% of deposits the previous week, showing that the financial situation is still unstable.

According to analysts, Bitcoin might keep increasing throughout the year even if the Fed stops raising interest rates, as many investors anticipate. However, the Fed issued a warning that an impending recession would result in instability.

Those concerns notwithstanding, when a major crypto of the magnitude of Bitcoin performs well, it bodes well for the entire industry, and enterprises such as Canaan Inc. (NASDAQ: CAN) could register an uptick in their business activities as a result of that positive momentum exhibited by Bitcoin so far this year.

Canaan Inc. (CAN), closed Wednesday's trading session at $2.62, up 2.3438%, on 1,358,422 volume. The average volume for the last 3 months is 32,771 and the stock's 52-week low/high is $1.87/$4.54.

The QualityStocks Company Corner

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, today announced that vehicle production will begin in July 2023 at Mullen's Manufacturing Center in Tunica, Mississippi. According to the announcement, Mullen's manufacturing group is collaborating with NRTC Automation ("NRTC") out of Birmingham, Alabama, for Class 3 assembly line installation and integration, including all robotics and automation systems for vehicle production. NRTC will support Mullen's Class 3 operation through launch and provide ongoing support of the production as Mullen ramps up to meet the full market demand from its commercial customers. "It's gratifying to see our Class 3 vehicle production line coming together in Tunica and even more validating to know we will have vehicles coming off the line and delivered to customers later this summer," said David Michery, CEO and chairman of Mullen Automotive.

To view the full press release, visit

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Wednesday's trading session at $1.23, up 0.819672%, on 57,503,477 volume. The average volume for the last 3 months is 215,627 and the stock's 52-week low/high is $1.17/$42.75.

Recent News

Jupiter Wellness Inc. (NASDAQ: JUPW)

The QualityStocks Daily Newsletter would like to spotlight Jupiter Wellness Inc. (NASDAQ: JUPW).

Pilates is a form of body conditioning and exercise that was developed in the 20th century. This disciplined practice focuses on different areas of the body, improving an individual's strength, flexibility and muscle tone while also alleviating pains and aches. This exercise has become increasingly popular in recent years, primarily because it can be done at home and is great for beginners. It can also be customized to fit an individual's health goals, regardless of one's sex, age, level of fitness and health status.

Pilates has many benefits apart from the ones listed above, including improving one's posture and mobility as well as strengthening and stabilizing an individual's core. Now, a new study has found that practicing this exercise a few times a week may help women overcome various sexual struggles.

The study was carried out by urologists from Turkey. The objective of the research was to determine whether there was a link between Pilates and libido, particularly in women. For their study, the investigators recruited 36 women between 20 and 50 years of age. When interventions such as Pilates don't yield the desired results, there are other alternatives available, such as the remedies commercialized by entities such as Jupiter Wellness Inc. (NASDAQ: JUPW). Women should know that sexual dysfunction can be managed or even reversed.

Jupiter Wellness Inc. (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary products.

Jupiter Wellness’s product pipeline, backed by clinical research to ensure efficacy, addresses a range of underserved conditions. The company’s revenue is generated through a combination of OTC and consumer product sales, contract research agreements, and licensing royalties.

Jupiter Wellness was formed in 2018 and is headquartered in Jupiter, Florida.

Products with Purpose

Jupiter Wellness’s product pipeline currently targets a variety of indications with underserved needs. These include:

  • Hair Loss – Jupiter Wellness’s Minoxidil Booster is a topical treatment that’s been clinically shown to increase the enzymes needed for minoxidil to work by up to 7x over a two-week period. The product has been licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, which expects to launch it commercially in 2023. The product is licensed to India-based Cosmofix Technovation Pvt. Ltd. and Sanpellegrino Cosmetics, and additional licensing opportunities are being pursued.
  • Psoriasis & VitiligoPhotocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. The product has been licensed abroad and is currently being launched commercially in India by Eris Oaknet Healthcare and Cosmofix Technovation under the brand name PhotoFirst. The product is also available in the U.S., and the company is working to find new partners in dermatology for expanded distribution.
  • Jellyfish Protection SunscreenNoStingz is a topical protection from jellyfish, sea lice, and UVA/UVB rays. It provides an effective barrier against the stinging mechanism of jellyfish cnidocytes, preventing the delivery of venom to the victim. NoStingz is currently available online through Amazon and Walmart, as well as in select stores.
  • EczemaJW-100 is a pre-revenue topical treatment for atopic dermatitis (eczema). In prior studies, JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. It is currently being evaluated in a Phase 3, double-blind, placebo-controlled multicenter trial.
  • BurnsJW-300 is a pre-revenue topical treatment for first-degree burns and sun exposure. In prior studies, JW-300 was shown to significantly lower the incidence of burns in patients exposed to UV radiation. It is currently being evaluated for sale as an “after sun” consumer product.
  • Cold SoresJW-400 is a pre-revenue topical treatment of herpes labialis (cold sores). A phase 1, double-blind, placebo-controlled investigational study is currently being planned for JW-400.
  • Sexual WellnessJW-500 is a pre-revenue topical treatment for female libido loss. In clinical studies, the topical formulation improved nipple sensitivity and alleviated associated sexual problems. Jupiter Wellness plans to file for a pre-IND meeting with the U.S. FDA within the next 12 months and intends to seek Orphan Drug Designation.
  • COVID-19-Induced TinnitusJW-600 is currently being evaluated in a triple-blind clinical study. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus

Management Team

Brian John is the CEO of Jupiter Wellness. For the past 20 years, he has been an investor and advisor to companies around the globe. He is the founder of a successful financial consulting firm specializing in helping emerging growth companies and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John also serves on the board of directors of The Learning Center at the Els Center of Excellence – a school for children with autism in Jupiter, Florida.

Doug McKinnon is the CFO of Jupiter Wellness. His 35+ year professional career includes financial, advisory, and operational experience across a broad spectrum of industry sectors, including oil and gas, technology, cannabis, and communications. He has served in C-Level positions in both private and public sectors, including as chairman and CEO of an American-stock-exchange-traded company; as VP – Chief Administrative Officer of a $12-billion-market-cap Nasdaq-traded company; as CFO of several publicly-held U.S., Canadian and Australian companies; and as CEO/CFO of various other private enterprises.

Dr. Glynn Wilson is the Chief Scientific Officer of Jupiter Wellness. He brings to the company an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals; Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals; and Founder, CEO, and Chairman of TapImmune Inc., which became Marker Therapeutics through a merger. At TapImmune, he licensed cancer vaccine technology platforms and established the clinical pipeline.

Jupiter Wellness Inc. (NASDAQ: JUPW), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen Infrastructure Corp. ("EverGen" or the "Company") (TSXV: EVGN) (OTCQX: EVGIF), today announced plans to release its 2023 first quarter financial results on Wednesday, May 24, 2023 , after market close. EverGen will hold a results and corporate update conference call at 10:00 a.m. eastern time on Thursday, May 25, 2023, hosted by Chief Executive Officer, Chase Edgelow.

Conference Call Details are as follows:

Date: Thursday, May 25, 2023
Time: 10:00 a.m. ET

Zoom Link:

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Wednesday's trading session at $2.26, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $1.365/$2.94.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore has set out to capitalize on critical mid-market separation of REE through its transformative RapidSX(TM) technology in a bid to address China's dominance in the rare oxide market

The company is confident in its approach and has even committed to investing $75 million in CapEx over the next four years to establish North America's first modern REE separation and purification facility

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a critical metals ("CM") separation technology company, understands the potential of the rare oxide market and the stake that China currently holds. According to CEO Pat Ryan, this industry is expected to reach $32 billion by the decade's end. However, with China controlling 90% of this sector, there has been a push by other countries to cut down dependence and seek out alternatives which, in turn, do away with the risks associated with China's dominance (

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is engaged in Rare Earth Element (REE) resource development and in commercializing its critical metals separation technology, RapidSX™, for the mining and metals extraction industry. The company is guided by principles of environmental, social and corporate governance (ESG) with a focus on disrupting China’s current dominance of the U.S. REE supply chain.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. It plans to aid in the development, through strategic partnerships, of a North American REE supply chain controlled by the U.S. and its allies.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Wednesday's trading session at $0.78, even for the day, on 1,010 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.40/$1.15.

Recent News

IGC Pharma Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight IGC Pharma Inc. (NYSE American: IGC).

Missouri launched recreational cannabis sales earlier in February, following approval of Amendment 3 in November 2022. This, according to a report by Brightfield Group, is the second fastest turnaround in the United States, only two weeks behind the record set by Arizona.

Thus far, Missouri has raked in $350 million in sales for both medical and recreational cannabis, according to data released by the Missouri Department of Health and Senior Services. Last month, the state brought in $91 million in recreational cannabis sales. This is on par with the $93.5 million in revenue generated in March and an increase from the $71.7 million sales from February. Medical marijuana sales make up the remainder that brings total sales to $350 million.

The state's adult-use market is growing at a rapid rate, especially in comparison to other states. The booming sales of recreational and medical marijuana in Missouri and other states that legalized the substance suggest that entities such as IGC Pharma Inc. (NYSE American: IGC), which are working to develop medicinal formulations from marijuana, could register success since preliminary studies as well as anecdotal reports point to this plant having therapeutic potential.

IGC Pharma Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule ( As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products ( such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand ( that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.


IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.


The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

IGC Pharma Inc. (NYSE American: IGC), closed Wednesday's trading session at $0.33, even for the day, on 138,849 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2785/$0.8432.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

The new legal market for marijuana in New York is growing, and with this comes an increase in demand. To help keep up, businesses in the state are finding new ways to turn marijuana into a range of products, including edibles such as chocolates and gummies.

Smokiez' National training manager Maddi Burch stated that edibles had become more popular as they appeal to those who didn't smoke. The demand for gummies at dispensaries in the state is particularly high, which has led many businesses to boost production.

For marijuana to be turned to edibles, it must undergo an extraction process. One extraction facility, urbanXtracts, starts by putting the plant through various machines and filters the extract THC from the plant. THC is one of the two primary compounds found in marijuana, the other being CBD. Unlike CBD, however, THC induces a high when ingested. As the innovations of marijuana companies pay off, there will be a trickle-down effect that could see ancillary businesses such as Advanced Container Technologies Inc. (OTC: ACTX) making more sales as marijuana growers move to ramp up their operations to meet the accelerating consumer demand.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.


Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.


ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Wednesday's trading session at $0.3, even for the day, on 10 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.073/$1.00.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Positive preclinical data was presented for the NPRL2 tumor suppressor gene

The studies used Genprex's non-viral ONCOPREX(R) Nanoparticle Delivery System in KRAS/STK11 mutant anti-PD1 resistant metastatic human non-small cell lung cancer ("NSCLC") humanized mouse models

Validates ONCOPREX(R) platform's ability to deliver other tumor suppressor genes to potentially address multiple types of cancer

ONCOPREX(R) Nanoparticle Delivery System is the novel non-viral platform being used for the company's lead drug candidate, REQORSA(R) Immunogene Therapy, initially targeting lung cancer

Genprex (NASDAQ: GNPX), A cutting-edge gene therapy company striving to improve the lives of cancer and diabetes patients through the creation of groundbreaking treatments, announced last month that its research collaborators presented positive preclinical data for the NPRL2 gene, which is a tumor suppressor gene. The presentation was given at the 2023 American Association of Cancer Research ("AACR") annual meeting, which took place from April 14-18, 2023, in Orlando, Florida.

Genprex Inc. (GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $0.7715, off by 3.2722%, on 226,207 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.7225/$2.67.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots ("ASRs") and blue light emergency communication systems, has received a new contract for three K5 ASRs from a semiconductor company in Texas. The new contract is the latest in a series of contracts Knightscope has announced as the company works to provide key services to protect vital industries.

According to the announcement, the semiconductor market reportedly totaled $600 billion in sales in 2021 and is projected to reach $1 trillion within this decade. "Semiconductors are the heart of contemporary electronics, enabling technologies that are essential to U.S. economic growth, national security, and international competitiveness to flourish," the announcement stated. "Numerous additional applications, including those in communications, computers, healthcare, military systems, transportation, and clean energy, advance on a near daily basis thanks to semiconductors. By providing the most advanced tools to support the safety and security of these facilities, Knightscope is fostering the development of other cutting-edge technologies like brain-inspired computing, virtual reality, energy-efficient sensing, automated devices, robots, and artificial intelligence that have the potential to positively impact society in a similar fashion."

To view the full press release, visit

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Wednesday's trading session at $0.4671, off by 6.5239%, on 2,743,318 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.445/$4.5197.

Recent News

CISO Global, Inc. (NASDAQ: CISO)

The QualityStocks Daily Newsletter would like to spotlight CISO Global, Inc. (NASDAQ: CISO).

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, has entered into definitive agreements with key investors. According to the announcement, the agreements are for the purchase and sale of 20 million shares of the company's common stock, sold at a purchase price of $0.20 per share in a registered direct offering. The company anticipates the offering, will total approximately $4 million, will close on or about May 19, 2023, and will be subject to customary closing conditions. CISO expects to use funds from the offering for general corporate purposes, including potentially working capital, capital expenditures, research and development expenditures, acquisitions of additional companies or technologies, and investments as well as to repay certain indebtedness.

To view the full press release, visit

CISO Global, Inc. (NASDAQ: CISO) is an industry leader in cybersecurity and compliance services. The company leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. Pulling disparate technologies, teams, and vendors together, CISO helps its clients enjoy a simpler and more successful journey to cyber resilience. Since 2019, CISO Global has worked to rapidly expand by acquiring world-class cybersecurity and compliance businesses with top-tier talent who utilize the latest technology to create innovative protection solutions.

The CISO Global workforce is comprised of cybersecurity experts spanning not only global geographies, but also specialties, industries, regulatory frameworks and focus areas. Its team includes audit and compliance specialists, certified forensics experts, ethical hackers, IEEE® certified biometric professionals, security engineers, around-the-clock analysts, and more – all backed by the most respected credentials in the industry. On an ongoing basis, the company works to identify cyber talent that is culturally aligned and that offers operating leverage through both existing customer revenue and relationships.

CISO Global has invested in enterprise solutions and executive talent to integrate its different organizations into an ecosystem that works together to provide complete cybersecurity through cross-pollination of solutions that begin at the network level and extend through technologies, people, policy, and practices. This ecosystem is intended to foster additional growth opportunities and drive overall recurring revenue. Once engaged, the company strives to become trusted advisors for customers’ cybersecurity and compliance demands by providing tailored security solutions based upon their organizational needs.

While cyber resilience requires cycles of continuous improvement, it is a journey that few in the current business and security climate seem to understand. With its deep bench of seasoned experts, CISO Global works to simplify that journey for its growing customer base, straightening out the curves and speeding up the process to resilience along the way.

Cybersecurity is a Culture, Not a Product

Integrating compliance and security, including principles of security by design, CISO Global helps its clients create an organization-wide culture of cybersecurity. Its offerings include audit and compliance, security operations center services, security engineering, virtual Chief Information Security Officer services, incident response, certified forensics, technical assessments and cybersecurity training.

In contrast to the majority of cybersecurity firms that specialize in a specific technology or service, CISO Global seeks to differentiate itself by remaining technology agnostic, focusing on accumulating highly sought-after subject matter experts. CISO Global believes that bringing together a world-class team of technological experts with multi-faceted proficiency in the critical aspects of cybersecurity is key to providing technology agnostic solutions to its clients in a business ecosystem that suffers from a chronic lack of highly skilled professionals.

CISO Global’s goal is to create a culture of security and to help quantify, define and capture a return on investment from information technology and cybersecurity spending. Its end-to-end, holistic process covers every aspect of clients’ cybersecurity and compliance requirements in an effort to promote greater efficiency and strengthen awareness about the integral role of internal team members in the cybersecurity culture of an organization.

As a result of this strategy, CISO Global customers receive an efficient engagement from a single partner that covers a wide range of their needs – addressing challenges more thoroughly and resolving problems more rapidly when compared to working with a host of vendors.

Market Outlook

According to an analysis by the firm Research and Markets, the global managed security services market was valued at $22.45 billion in 2020 and is projected to reach $77.01 billion by 2030, growing at a CAGR of 12.8% through the forecast period.

An expected increase in cybercrime, cost effectiveness of provided solutions and stringent mandatory government regulations aimed at protecting corporate data will drive the global managed security services market for the foreseeable future.

In addition, the documented and growing use of mobile devices in the workplace and the rise in captured and stored digital data serve to fuel market growth. Moreover, growing awareness about the critical nature of data security, the growing importance of e-business and demand for customized services is expected to offer ample opportunities for expansion of the market during the forecast period.

Management Team

David Jemmett is CEO and founder of CISO Global. He has more than 35 years of executive management and technology experience with telecommunications, managed services, and cybersecurity consulting services. He previously held positions as CEO of GenResults, a leading provider of security consulting services and technology solutions, and as CTO and founder at ClearData Networks, a HIPAA-compliant HealthDATA cloud hosting platform.

Dave Bennett is COO at CISO Global. Since 2015, he has served on the President’s STEM Advisory Board of Grand Canyon University. Before joining CISO Global, he served as Chief Product Officer at Experian Health and as Senior Vice President, Product for Gainwell Technologies. He has also held positions as Vice President and Worldwide Head of Build, Healthcare and Life Sciences at DXC Technology, and as EVP, Product and Strategy at Orion Health.

Ashley Devoto is President and Chief Information Security Officer at CISO Global. Over the past 17 years, Devoto has worked with the cybersecurity elite to design, build, and operate world-class cybersecurity programs for large, diverse organizations in both government and commercial enterprises. Prior to joining CISO, Devoto served as CISO for Booz Allen Hamilton, as business information security officer (BISO) at Bank of America, and as a cyberspace operations officer in the United States Air Force.

Deb Smith is CFO at CISO Global. Prior to assuming that position, she was the company’s EVP, Finance and Accounting. She has also served as SVP, Global Accounting at International Cruise and Excursions Inc., and as Chief Accounting Officer for BeyondTrust, an information security software company. She has also held the positions of Corporate Controller at Aspect Software and Assistant Controller at JDA Software.

CISO Global, Inc. (NASDAQ: CISO), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG) today announced that its wholly owned subsidiary, MyTravelVentures, just completed its inaugural Venture Trip at the Sensira Resort and Spa in Cancun, Mexico. MyTravelVentures, a subscription-based travel company that offers access to wholesale travel savings for any consumer, provides its members full access to exclusive deals across the travel industry. This includes savings of up to 65% on services like flights, hotels, transportation and events, as well as nontravel-related services such as retailer discounts, cash-back programs and telehealth services. "We couldn't be more excited about our first Venture Trip in Cancun," said MyTravelVentures VP Dave Dove. "It was the ultimate getaway. We had over 50 members in attendance, an amazing resort, a 10-course meal at the Galerie des Sans restaurant, a poker night and so much more. And the best part, hands down, was connecting with such a diverse and fun community of people."

To view the full press release, visit

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

469.304.9400 x 201

Sharing Services Global Corporation (SHRG), closed the day's trading session at $1.01, up 23.17%, on 276,351 volume with 217 trades. The average volume for the last 3 months is 279,074 and the stock's 52-week low/high is $0.27/$2.54.

Recent News

Electronic Servitor Publication Network Inc. (OTCQB: XESP)

The QualityStocks Daily Newsletter would like to spotlight Electronic Servitor Publication Network Inc. (OTCQB: XESP).

Electronic Servitor Publication Network Inc. (OTCQB: XESP) is a digital engagement company offering a managed service which provides digital activation and engagement solutions to companies that seek to optimize their growth. Its managed service is powered by a proven, proprietary technology – the Digital Engagement Engine™. This technology provides intelligent interaction management, dynamic content provisioning, and a logic-driven workflow, which creates digital experiences that accelerate an audience from awareness to action – driving growth.

Electronic Servitor Publication Network’s services are designed to drive growth for both established and developing organizations. Through the optimization of digital interactions within current and new communities, the Digital Engagement Engine™ ensures that client content is relevant, reaches the right audience, and connects with the intended person at the right time.

The company calls it ‘Growth as a Service’.

Client implementation is nearly effortless, since the solution is completely managed by the Electronic Servitor Publication Network team. This business model allows clients to focus on their brands, core product offerings, and content creation, while the company manages the technology and outcome.

The company is headquartered in Minneapolis, Minnesota.


Electronic Servitor Publication Network’s Digital Engagement Engine™ utilizes a combination of automation, unique data management, and a modern workflow built on a microservices architecture to achieve greater reach and lift. Using sophisticated data analysis and smart technology, the Digital Engagement Engine™ provides companies with the ability to maintain complete control of their content while creating meaningful relationships with new customers and revenue streams.

The Digital Engagement Engine™ isn’t just another marketing or technology tool; it’s a way to develop real connections with target markets.

Market Outlook

According to a report by, an award-winning market research firm, the global customer engagement solutions market was estimated at $19.3 billion in 2022 and is forecast to grow to $32.2 billion by 2027, achieving a CAGR of 10.8% during the forecast period.

The report notes that these engagement solutions are vital to companies seeking to widen their customer bases, reduce customer churn rates and increase customer retention. These perceived benefits of customer engagement solutions are likely to drive their growing adoption around the globe during the forecast period, according to the report.

Management Team

Peter Hager is President and CEO of Electronic Servitor. He joined the company from Pointward Inc., a medtech customer engagement agency that provided solutions to drive market entry, growth, and commercialization for Fortune 500 health care brands and medtech startups. He has founded and managed multiple technology, professional services and medtech organizations throughout his career. Mr. Hager holds a bachelor’s degree from Macalester College in St. Paul, Minnesota, with concentrations in economics and psychology.

Jim Kellogg is CFO of Electronic Servitor. He has served as the principal of J. Kellogg & Company Inc., a business and tax consultant, since 2005. He has provided legal support to clients’ business valuations, business interruption and divorce property valuations. He has worked as a professional tax adviser since 1983. Mr. Kellogg obtained his JD with emphasis on taxation from Western State University College of Law and was certified as a financial planner by the College for Financial Planning in 1990.

Thomas (Denny) Spruce, RPh, is COO of Electronic Servitor. He oversees company infrastructure, regulatory reporting, and strategic partner relationships, among other roles and responsibilities. He joined the company in March 2022 and, since that time, has implemented foundational support processes, developed contractual relationships with service providers, managed financial and regulatory reporting and overseen contract development and management with the legal team. Mr. Spruce obtained a BS in Pharmacy from the University of Arkansas.

Electronic Servitor Publication Network Inc. (XESP), closed Wednesday's trading session at $0.0677, up 12.6456%, on 7,400 volume. The average volume for the last 3 months is 231,965 and the stock's 52-week low/high is $0.03/$0.2245.

Recent News

Correlate Infrastructure Partners Inc. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Infrastructure Partners Inc. (OTCQB: CIPI).

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment solutions for the commercial real estate industry. The company believes scaling distributed clean energy solutions is critical in mitigating the effects of climate change. CIPI is at the forefront in creating an industry-leading energy solution and financing platform for the commercial and industrial sector. The company sees tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale.

The opportunity exists to remove friction between today’s legacy finance process and the needed clean-energy upgrades developed within the company’s program technologies. For the U.S. to reach its 2050 carbon goals, 200,000 commercial buildings must be retrofitted every year until that date. That represents approximately a 5-10x increase over the 2022 industry process run rate.

CIPI announced completion of its acquisition of 100% of the equity of Correlate Inc. and Loyal Enterprises LLC dba Solar Site Design on December 28, 2021. The company notes these acquisitions occurred at a key inflection point of its growth. CIPI currently enjoys channel and sales partnerships with Fortune 250 companies and a strong, proven industry network.

The company’s transparent, leading-edge model changes value delivery for both facility owners and proven solution providers seeking scale. CIPI believes its rapid growth is due to industry demand for actionable, cashflow positive energy programs and the underlying carbon reduction mandates taking effect globally.

CIPI has filed with the SEC for a name change to Correlate Infrastructure Partners Inc., which will more closely reflect its new platform and growth focus. The company has been aggressively moving to rebrand, with efforts including a revised website, investor presentation materials and an investor relations awareness campaign. The company’s shares will continue to trade on the OTCQB Venture Market under the current ‘CIPI’ ticker symbol until changes are approved.


Correlate, founded in 2015, is a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions focused on locally-sited solar, energy storage, EV infrastructure, and intelligent efficiency measures. Its unique data-driven approach is powered by proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network to help building owners profit from fully funded, turnkey decarbonization and facility health programs. The platform is designed for commercial and industrial real estate owners seeking to significantly improve net operating income while meeting carbon reduction goals. The platform provides energy programs for commercial property portfolios and requires no upfront capital. Client organizations reduce their risk and generate more profits by leveraging Correlate’s unique payment programs to put more cash in the bank. Deploying Correlate’s strategic energy programs and energy management systems allows property-owning organizations to complete big energy changes across their portfolios.

Solar Site Design, founded in 2013, is a U.S. Department of Energy Sunshot Catalyst winner that provides customer acquisition and project development tools for the commercial solar industry. Its commercial marketplace platform connects highly qualified project opportunities to leading solar construction companies nationwide. The Solar Site Design platform gives commercial and industrial property owners access to the best price for a commercial solar system. Commercial solar analysts provide property owners a site assessment and working project proposal. Solar Site Design’s team of solar engineers finalize the design while approved financing providers help clients explore financing options for their projects. Then, approved contractors in Solar Site Design’s Marketplace bid on the projects, ensuring commercial and industrial property owners get the best estimates for their projects. Solar Site Design’s marketplace process promotes transparency and fair pricing. Its team of experts has nearly 20 years of experience in the solar industry. Only reputable, experienced, certified (NABCEP), licensed, bonded and insured contractors are accepted into the Solar Site Design Marketplace.

Market Outlook

CIPI is in a rapidly growing market with a unique offering to address a total market of more than 5.9 million commercial buildings in the United States, according to the U.S. Energy Information Administration. Currently, the company’s wholly owned subsidiaries, Correlate and the Solar Site Design, have an opportunity pipeline of over $100 million in commercial projects with more than $20 million in awarded backlog. According to the Rocky Mountain Institute, portfolio energy optimization is a $290 billion market in the United States driving deep financial savings and energy efficiency across the commercial sector.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon, and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings. Yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which has very different needs than traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue known as the “split incentive”, unlocking the majority of the addressable market.

Management Team

CIPI has in place a nationally recognized management team that has been active in the energy market since 2005.

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

David Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jason Loyet is VP of Commercial Sales of Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Deke Welling is Head of Project Development and Fulfillment Services at Correlate Inc. He has over 19 years’ experience in the energy industry with an emphasis on renewables and energy efficiency over the past seven years. Prior to entering the renewables sector, Mr. Welling was the CEO of Welling Resources, an energy development company focused on the exploration of oil and natural gas reserves in the U.S. It was this experience that led him into the renewables sector and leading a charge for more sustainable resources. Additionally, Mr. Welling also served as the CEO of Circle L Solar Inc., a top 100 solar installer in the United States since 2016. Through his leadership, Circle L Solar experienced a growth rate of over 2,250% from 2016 to 2019, resulting in his company being listed on the Inc. 5000 list of the fastest growing private companies in the U.S. (Rank #176) and being named ‘Top Energy Company’ and ‘Entrepreneur of Year for the Energy Industry’ by the American Business Awards® in 2019 and again for ‘Entrepreneur of the Year’ in 2021.

Kevin Warren is Head of Construction and Development Engineering at Correlate Inc. He is a solar veteran with over 12 years of experience in the field. Prior to co-founding CLS, Mr. Warren was the owner of Beacon Consulting and has originated, consulted, designed and/or engineered over 122 MW of PV installations ranging from small commercial to utility scale projects throughout Texas, California, Colorado and North Carolina. He holds a Photovoltaic Technical Sales Professional Certification from the North American Board of Certified Energy Practitioners and certifications from Solar Energy International in PV Installation, PV Technical Sales, PV battery-based design, PV design and engineering, and PV operations and maintenance. Along with PV expertise, Mr. Warren is a LEED Green Building Associate, a certified building analyst from the Building Performance Institute, a Certified Renewable Energy Professional from the Association of Energy Engineers and holds a designation in High-Performance Sustainable Buildings from the BOMI Institute. He studied Electrical Engineering at the University of Texas at Arlington.

Tom Kunhardt is Director of Customer Success at Correlate. He previously held a similar position at Clean.Tech and was Corporate Trainer, Learning & Development, at NRG Energy. He has 15 years of experience in the solar and clean energy industries helping homeowners and businesses find solutions to their energy needs. He holds a bachelor’s degree from the University of Massachusetts.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), closed Wednesday's trading session at $0.5, even for the day. The average volume for the last 3 months is 382,255 and the stock's 52-week low/high is $0.3501/$1.70.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.